GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
EBITDA Growth
2.20%
TTM · Period ending:
GSK EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported2.20%period ending
Latest reported2.20%period ending
GSK TTM EBITDA YoY % (30.32% → 2.20%)
Year-over-year change
High-resolution chart · PNG
GSK ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 346.1568% | |
| 565.5078% | |
| 302.7026% | |
| -82.3887% | |
| -15.6547% | |
| -44.3147% | |
| -1.3196% | |
| 37.2196% | |
| 27.0244% | |
| -36.6789% | |
| -42.0479% | |
| -66.2137% | |
| -70.7725% | |
| -44.3624% | |
| -43.0086% | |
| -48.1596% | |
| 91.6867% | |
| 142.541% | |
| 442.1409% | |
| 62.7365% | |
| -16.6478% | |
| -27.1183% | |
| -17.549% | |
| 8.483% | |
| 5.4387% | |
| 8.589% | |
| 22.3839% | |
| 26.4144% | |
| 61.471% | |
| 53.1086% | |
| 8.8379% | |
| -21.6987% | |
| -28.6278% | |
| -20.5843% | |
| 14.8859% | |
| 85.3156% | |
| 59.6422% | |
| 28.5285% | |
| -2.4083% | |
| -20.685% | |
| -9.3054% | |
| 9.1878% | |
| 25.7483% | |
| 29.4366% | |
| 22.8591% | |
| 15.7828% | |
| 8.6665% | |
| 23.939% | |
| 15.3565% | |
| 7.2108% | |
| 9.5737% | |
| 12.3516% | |
| 23.0937% | |
| 30.8773% | |
| 30.3176% |